Colorado 2025 Regular Session

Colorado House Bill HJR1021

Introduced
2/19/25  
Refer
2/19/25  
Engrossed
2/28/25  
Refer
2/28/25  
Passed
3/12/25  

Caption

February 28 Rare Disease Day

Impact

The resolution signifies an important acknowledgment of the difficulties associated with rare diseases, including the need for knowledgeable medical providers and appropriate treatments. It aims to unify constituents and promote a supportive environment for individuals who face the often life-altering effects of such conditions. The declaration of a dedicated day serves not just as a recognition but also as a potential catalyst for policy discussions surrounding health care accessibility and funding for research into rare diseases.

Summary

HJR1021 is a resolution proposed in the Colorado General Assembly that declares February 28, 2025, as Rare Disease Day in Colorado. This resolution aims to raise awareness about the challenges faced by individuals and families affected by rare diseases, which are defined as conditions affecting fewer than 200,000 Americans. The resolution highlights that approximately 15 million children in the United States suffer from rare diseases, with unfortunate mortality rates that emphasize the urgent need for enhanced care and understanding of these conditions.

Sentiment

Overall, the sentiment surrounding HJR1021 is positive, as it seeks to foster community support and awareness. Legislators from both sides have recognized the importance of standing in solidarity with those affected by rare diseases. The resolution's proponents are motivated by compassion and a desire to enhance the quality of life for those living with these often misunderstood conditions, aiming to inspire collective action and community engagement.

Contention

While no significant points of contention emerged regarding HJR1021, discussions around rare diseases often reflect broader systemic issues related to healthcare equity and access. There exists ongoing debate on whether enough legislative emphasis is placed on funding research and treatment avenues for rare diseases, especially given that fewer than 5% of over 10,000 identified rare diseases currently have FDA-approved treatments. This resolution sparks necessary conversations and could lay groundwork for future legislative initiatives related to healthcare reforms and patient advocacy.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.